Success Metrics

Clinical Success Rate
86.7%

Based on 13 completed trials

Completion Rate
87%(13/15)
Active Trials
0(0%)
Results Posted
54%(7 trials)
Terminated
2(13%)

Phase Distribution

Ph phase_1
1
6%
Ph not_applicable
2
13%
Ph phase_2
2
13%
Ph phase_3
3
19%
Ph phase_4
8
50%

Phase Distribution

1

Early Stage

2

Mid Stage

11

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
1(6.3%)
Phase 2Efficacy & side effects
2(12.5%)
Phase 3Large-scale testing
3(18.8%)
Phase 4Post-market surveillance
8(50.0%)
N/ANon-phased studies
2(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.3%

13 of 16 finished

Non-Completion Rate

18.8%

3 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Completed(13)
Terminated(3)

Detailed Status

Completed13
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
86.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.3%)
Phase 22 (12.5%)
Phase 33 (18.8%)
Phase 48 (50.0%)
N/A2 (12.5%)

Trials by Status

terminated213%
withdrawn16%
completed1381%

Recent Activity

0 active trials
Showing 5 of 16
terminatedphase_2

A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder

NCT01114698
completedphase_4

Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD

NCT02977299
completedphase_4

A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression

NCT00644982
completedphase_3

Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder

NCT00151450
completednot_applicable

Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?

NCT00186264
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT01114698Phase 2

A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder

Terminated
NCT02977299Phase 4

Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD

Completed
NCT00644982Phase 4

A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression

Completed
NCT00151450Phase 3

Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder

Completed
NCT00186264Not Applicable

Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?

Completed
NCT02181231Phase 1

Buprenorphine Used With Treatment Resistant Depression in Older Adults

Completed
NCT01360866Phase 3

Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)

Completed
NCT02407704Phase 4

A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise

Completed
NCT00620776Phase 2

Combined Treatment for Generalized Anxiety Disorder (GAD)

Completed
NCT00183274Phase 4

Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR

Completed
NCT02433353Phase 4

Results From a 24 Week Trial of EMDR Combined With Venlafaxine XR

Withdrawn
NCT00926835Phase 4

Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients

Terminated
NCT00179283Phase 3

Sertraline vs. Venlafaxine XR

Completed
NCT00592384Phase 4

Project to Improve Symptoms and Mood in People With Spinal Cord Injury

Completed
NCT01418209Not Applicable

MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms

Completed
NCT00546923Phase 4

Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16